Product Information
LOPINAVIR-RITONAVR 200-50 MG TB is a generic product labeled by Laurus Labs Limited, priced at $4.4434 per EA under NDC 42385093412. Its NADAC has been published 123 times since Apr 17, 2024.
FDA first approved this application on Mar 21, 2022. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
200; 50 mg/1; mg/1
Manufacturer
Laurus Labs LimitedNDC
42385093412
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
LOPINAVIR; RITONAVIRApproval Type
Generic (ANDA)
FDA Application
ANDA213857FDA Approved
3/21/2022
TE Code
AB
On Market Since
3/22/2022
Pharmacological Classes
Price Statistics
The NADAC for LOPINAVIR-RITONAVR 200-50 MG TB has been published 123 times since Apr 17, 2024, and over the history we have for it it has declined 8.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $4.4434 per EA |
|---|---|
| All-time high | $5.3737 (Dec 11, 2024) |
| All-time low | $4.1706 (Jun 19, 2024) |
| 52-week high | $5.2427 |
| 52-week low | $4.3788 |
| Median price | $4.5520 |
| Average price | $4.6184 |
| Largest weekly change | +15.8% (Nov 20, 2024) |
| Weeks tracked | 123 |
| Tracking since | Apr 17, 2024 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of LOPINAVIR-RITONAVR 200-50 MG TB?
The current National Average Drug Acquisition Cost (NADAC) for LOPINAVIR-RITONAVR 200-50 MG TB, manufactured by Laurus Labs Limited, is $4.4434 per EA (NDC 42385093412), effective Aug 19, 2026.
How has the price of LOPINAVIR-RITONAVR 200-50 MG TB changed over time?
Over the history we have for it, the NADAC for LOPINAVIR-RITONAVR 200-50 MG TB has declined 8.5%. It has been tracked across 123 weekly CMS publications since Apr 17, 2024.
What are the highest and lowest recorded NADAC prices for LOPINAVIR-RITONAVR 200-50 MG TB?
Since Apr 17, 2024, the NADAC for LOPINAVIR-RITONAVR 200-50 MG TB has ranged from a low of $4.1706 (Jun 19, 2024) to a high of $5.3737 (Dec 11, 2024), with a median of $4.5520 per EA.
Are there cheaper alternatives to LOPINAVIR-RITONAVR 200-50 MG TB?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as LOPINAVIR-RITONAVR 200-50 MG TB in a comparable dosage form, but none are currently priced below it.
Who manufactures LOPINAVIR-RITONAVR 200-50 MG TB?
LOPINAVIR-RITONAVR 200-50 MG TB (NDC 42385093412) is labeled by Laurus Labs Limited, and CMS classifies it as a generic product.